Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

XEMBIFY 200 MG/ML SOLUCION INYECTABLE SUBCUTANEA - CIMA-AEMPS Drug Approval Details

Approvals/CIMA-AEMPS/XEMBIFY 200 MG/ML SOLUCION INYECTABLE SUBCUTANEA

Approved

STANDARD

XEMBIFY 200 MG/ML SOLUCION INYECTABLE SUBCUTANEA

Instituto Grifols S.A.🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Date: Mar 3, 2022
Approval ID: f1cf28a4fede75fa
Company: Instituto Grifols S.A.
Type: Standard

Approval Details

Approval Id: f1cf28a4fede75fa
Drug Cima Aemps Name: XEMBIFY 200 MG/ML SOLUCION INYECTABLE SUBCUTANEA
Register Number: 86544
Holder Company Name: Instituto Grifols S.A.
Marketing Company Name: Instituto Grifols S.A.
Holder Company Detail Path: /organization/instituto-grifols-sa
Marketing Company Detail Path: /organization/instituto-grifols-sa
Authorization Date: 2022-03-03
Dosage Form: SOLUCIÓN INYECTABLE
Dose: 200 mg/ml
Route Of Administration: VÍA SUBCUTÁNEA
Prescription Type: Uso Hospitalario
Commercialized: Yes
Company Name: Instituto Grifols S.A.
Company Detail Path: /organization/instituto-grifols-sa

Company Information

Pharmaceutical Company Name: INSTITUTO GRIFOLS SA
Country Name: Spain
City Name: parets del valles,barcelona,country_es
Address: CALLE CAN GUASCH (PG LEVANTE) 2

Active Ingredients

INMUNOGLOBULINA HUMANA NORMAL

18-22 PORCENTAJE

Approved

Quick Info

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Mar 3, 2022

Approval ID

f1cf28a4fede75fa

Type

Standard

Back to CIMA-AEMPS Approvals